Targeting ATR in Soft-tissue Sarcomas — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Targeting ATR in Soft-tissue Sarcomas — Stella

Home/Leiomyosarcoma, Adult/

View on ClinicalTrials.gov

Recruiting

Back to Leiomyosarcoma, Adult trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

France

Institut Bergonié, Bordeaux

Centre Leon Berard, Lyon

CHU Poitiers, Poitiers

Institut de Cancérologie de l'Ouest, Saint-Herblain

IUCT Oncopôle, Toulouse

Institut Gustave Roussy, Villejuif

Key details

Phase

Safety & dosing

Sponsor

Institut Bergonié

Collaborators

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Enrollment target

~72 participants

Started

February 2022

Primary completion

June 2026

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.